Language

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.   

Select Language

Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients

Destruction of leukaemia cell, conceptual image. 3D illustration which can be used to illustrate blood cancer treatment

A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]

Multiple Myeloma Research Foundation (MMRF) – Team Virginia Cancer Specialists!

Dr. Patel Mmrf Team 2023 3

This past Saturday, September 30, 2023 – Honorary Event Chair Dipti Patel-Donnelly, MD and Team Virginia Cancer Specialists participated in the Multiple Myeloma Research Foundation (MMRF) 5K Run/Walk at the National Harbor. The Walk raises money and brings a smarter, faster cure to every multiple myeloma patient. This year, team Virginia Cancer Specialists raised $6,000! […]